Major events with Dendreon have usually resulted in a significant effect on Prima.
Same old. However we all know the fundamentals for Prima are essentially unchanged.
What has changed is that it is now starkly clear that Prima, as a biotech in research phase, is a high risk speccy.
Many here, and I suspect elsewhere, had forgotten that. I've been criticised in the past on this forum for pointing that out and warning people to "don't bet the farm" on it.
I still have a lot of confidence in the future of Prima and Cvac. That's why I increased my holding by 50% yesterday.
As sure as night follows day, along the way to Phase III results, there will be a continuing roller coaster ride. It goes with the territory.
Major events with Dendreon have usually resulted in a...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |